FDA warns on compounded GLP‑1s amid safety reports
FDA warns on compounded GLP‑1s after tallying over 1,700 adverse event reports related to semaglutide and tirzepatide—compounded products aren’t FDA‑reviewed.
Plain-English, sourced guidance — updated as the science moves.
FDA warns on compounded GLP‑1s after tallying over 1,700 adverse event reports related to semaglutide and tirzepatide—compounded products aren’t FDA‑reviewed.
FDA’s warning letter to Empower Pharmacy raises safety and legality concerns over compounded semaglutide and tirzepatide under insanitary conditions.
Wondering how GLP-1 medications affect PCOS hormones and your menstrual cycle? Here's what the latest research shows—and what to ask your doctor.
GLP-1 dry mouth is a real but underreported side effect. Learn what recent research says about causes, dental risks, and how to talk to your doctor.
GLP-1 body composition changes include muscle loss alongside fat. Learn what the research says and how to protect muscle while losing weight on GLP-1 therapy.
Economists find that GLP‑1 weight‑loss drugs improve health but don’t affect employment, mental health, marriage—manage expectations, treat health gains as gains.
Can fasting raise testosterone in obese men? Here's what peer-reviewed research on fasting and testosterone actually shows—and what to ask your doctor.
A predictive model shows week‑8 weight loss on GLP‑1 medications best forecasts six‑month weight‑loss outcomes and engagement, helping set realistic expectations early.
Real‑world study finds goal‑setting with tirzepatide predicts better weight‑loss outcomes in over 80,000 users without other health conditions.
GLP-1 and aging research reveals how diet, appetite changes, and metabolic shifts interact. Learn what studies say and what to ask your doctor.
GLP-1 response rates vary widely between patients. Here's what recent clinical research reveals about who loses the most weight and why. Not medical advice.
Aleniglipron oral GLP‑1 showed up to ~11% weight loss by week 36 in a Phase 2b trial, with tolerable side effects—hinting at a future non‑injectable option.
Curious about GLP-1 and blood pressure? Here's what recent peer-reviewed research says about these medications and hypertension control.
Research on PCOS and ovulation shows GLP-1 medications may restore menstrual cycles and improve hormonal markers. Here's what the evidence actually says.
Real‑world data suggests people on GLP‑1s take fewer steps and report less vigorous activity, pointing to reduced movement motivation rather than physical limitation.
Curious about GLP-1 and liver health? Here's what peer-reviewed research says about these medications and metabolic liver disease. Not medical advice.
Curious about intermittent fasting? Explore what the latest research says about weight, metabolism, and health—plus when to talk to your doctor.
The FDA declared the semaglutide and tirzepatide shortages over, and the easy-access window for compounded copies has closed. Here is what is still permitted, what is not, and why patients are getting warning-letter headlines. Not medical or legal advice.
What to expect on liraglutide (Saxenda, Victoza) — a daily-injection GLP-1 with a familiar gut-side-effect profile, plus the serious warnings and management tips. Not medical advice.
What to expect on semaglutide (Wegovy, Ozempic) — the common gut side effects, the rare but serious ones to know, and practical ways to make the first months easier. Not medical advice.
What to expect on tirzepatide (Zepbound, Mounjaro) — the common gut side effects with real trial rates, the serious ones to watch, and how to make titration easier. Not medical advice.
Wegovy and Zepbound are the two GLP-1 medications FDA-approved for weight loss. A head-to-head trial gives Zepbound the edge on pounds lost — but the right choice depends on your health, coverage, and tolerance. Not medical advice.
Discover GLP-1 nutrition tips backed by research—what to eat, which nutrients to watch, and how to protect muscle while on GLP-1 therapy.
Curious about GLP-1 medications? This consumer guide covers how they work, who they help, and what real-world results look like. Not medical advice.
New to GLP-1 medications? Learn how GLP-1 drugs work, what the research says about weight loss, and what to ask your doctor before starting.
Intermittent fasting isn't one-size-fits-all across the month — and stacked on a GLP-1, the late-luteal week deserves extra care.
Premenstrual hunger is real physiology. Here's how it collides — sometimes helpfully — with a GLP-1's appetite suppression.
Fast weight loss and low intake can disrupt your cycle. Here's how to tell the difference between normal and a red flag.
The 'train with your cycle' advice is everywhere. Here's what the evidence really supports — and what to do with it on a GLP-1.
Intermittent fasting and appetite-suppressing medication can stack in ways that hit women differently. Start here.
Rapid weight loss can cost you muscle. Here's why protein and resistance training matter more than ever.
Semaglutide, tirzepatide, and the rest — what these drugs are, how they work, and what to actually expect.